A nano-sized medicine boosts the anti-cancer immune response and eradicates tumors in mice. Researchers at Washington University School of Medicine in St. Louis, working with colleagues at ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.

A team of scientists and physicians at Mass General Brigham has developed a single-dose oral cholera vaccine and tested it in ...

Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin had an association with reduced cancer risk among older adults with clonal hematopoiesis.

Aspirin has been labeled as a promising agent for colorectal cancer (CRC) prevention, with analyses suggesting low doses can reduce CRC risk as well as CRC recurrence rates. Could daily low-dose ...

The effectiveness of daily low-dose aspirin in reducing cancer risk varied widely across the study cohort, indicating personalized treatment approaches would be beneficial. Clonal hematopoiesis of ...

Results from two randomized trials showed that a lower dose of ribociclib reduced adverse events in women with HR-positive/HER-negative breast cancer. While ...

A new clinical trial is looking at whether getting a one-time dose of radiation, rather than multiple, can be effective for certain cancer patients. And the Prince George led trial is expanding ...

A common, over-the-counter form of vitamin B3 has emerged as an inexpensive ally in protecting us from skin cancer, lowering the risk by an average of 14% and increasing to a massive 54% for anyone ...

Low-dose aspirin significantly reduced colorectal cancer recurrence in patients with PI3K pathway gene alterations, nearly halving recurrence rates over three years compared to placebo. The study ...

A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study, a low dose of aspirin was shown to slash recurrence in half for patients ...